The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation.

Midori Nakagaki Glen A Kennedy Nicole Clare Gavin Alexandra M Clavarino Karen Whitfield

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

Severe oral mucositis was associated with myeloablative TBI, methotrexate and melphalan in combination with methotrexate and in BEAM. Use of PTCy was preferable over methotrexate to prevent oral mucositis.

Keyphrases

high dose
stem cell transplantation
radiation induced
low dose
patients undergoing
early onset
traumatic brain injury
chemotherapy induced
risk factors